Entrada Therapeutics, Inc. (TRDA) Ownership

$6.16

$0.31 (5.3%)
Last update: 04:00 PM EST
Day's range
$5.83
Day's range
$6.29

Entrada Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BAKER BROS. ADVISORS LP 08/14/2025 4.87 M $32.70 M   0.00% 11.77%
MPM ASSET MANAGEMENT LLC 08/14/2025 4.38 M $29.44 M   0.00% 10.60%
5AM VENTURE MANAGEMENT, LLC 08/14/2025 4.31 M $28.95 M   -2.27% 10.42%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2025 2.57 M $17.26 M   -6.19% 6.21%
BLACKROCK, INC. 08/12/2025 2.02 M $13.59 M   1.57% 4.89%
VANGUARD GROUP INC 08/11/2025 1.60 M $10.78 M   1.86% 3.88%
JANUS HENDERSON GROUP PLC 08/14/2025 1.52 M $10.21 M   -28.30% 3.68%
WELLINGTON MANAGEMENT GROUP LLP 08/14/2025 1.06 M $7.13 M   0.70% 2.57%
STEPSTONE GROUP LP 08/13/2025 761.28 K $5.12 M   0.00% 1.84%
GEODE CAPITAL MANAGEMENT, LLC 08/08/2025 631.55 K $4.24 M   7.21% 1.53%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2025 584.96 K $3.93 M   0.00% 1.42%
FMR LLC 08/14/2025 496.13 K $3.33 M   -59.98% 1.20%
STATE STREET CORP 08/14/2025 495.86 K $3.33 M   0.30% 1.20%
DIMENSIONAL FUND ADVISORS LP 08/12/2025 423.99 K $2.85 M   29.61% 1.03%
RENAISSANCE TECHNOLOGIES LLC 08/13/2025 379.50 K $2.55 M   15.53% 0.92%
NORTHERN TRUST CORP 08/13/2025 300.32 K $2.02 M   -3.18% 0.73%
ROYCE & ASSOCIATES LP 08/11/2025 223.25 K $1.50 M   100.00% 0.54%
JACOBS LEVY EQUITY MANAGEMENT, INC 08/14/2025 220.74 K $1.48 M   4.68% 0.53%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/12/2025 203.69 K $1.37 M   5.70% 0.49%
MILLENNIUM MANAGEMENT LLC 08/14/2025 170.32 K $1.14 M   100.00% 0.41%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2025 133.73 K $898.67 K   435.07% 0.32%
MOORE CAPITAL MANAGEMENT, LP 08/14/2025 105.00 K $705.60 K   0.00% 0.25%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 08/13/2025 102.01 K $685.49 K   -17.67% 0.25%
BANK OF NEW YORK MELLON CORP 08/05/2025 98.03 K $658.75 K   -2.03% 0.24%
FEDERATED HERMES, INC. 08/13/2025 96.69 K $649.73 K   -2.06% 0.23%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 08/08/2025 87.39 K $587.24 K   1.25% 0.21%
FIRST TRUST ADVISORS LP 08/13/2025 75.12 K $504.81 K   3.63% 0.18%
AMERICAN CENTURY COMPANIES INC 08/12/2025 75.09 K $504.63 K   10.77% 0.18%
BARCLAYS PLC 08/14/2025 58.08 K $391.00 K   46.48% 0.14%
NUVEEN, LLC 08/12/2025 56.42 K $379.12 K   -15.82% 0.14%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 08/14/2025 55.82 K $375.14 K   -1.15% 0.14%
JANE STREET GROUP, LLC 08/14/2025 51.16 K $343.78 K   100.00% 0.12%
NAN FUNG GROUP HOLDINGS LTD 08/13/2025 49.08 K $329.83 K   0.00% 0.12%
TD ASSET MANAGEMENT INC 07/28/2025 47.79 K $321.14 K   0.00% 0.12%
ACADIAN ASSET MANAGEMENT LLC 08/07/2025 45.81 K $306.00 K   116.67% 0.11%
STRS OHIO 08/04/2025 45.00 K $302.40 K   7.66% 0.11%
AMERIPRISE FINANCIAL INC 08/14/2025 44.95 K $302.04 K   9.56% 0.11%
LOS ANGELES CAPITAL MANAGEMENT LLC 08/07/2025 44.63 K $299.93 K   60.59% 0.11%
QUEST PARTNERS LLC 07/31/2025 39.63 K $266.28 K   239.78% 0.10%
MARTINGALE ASSET MANAGEMENT L P 08/11/2025 39.46 K $265.19 K   -1.74% 0.10%
RHUMBLINE ADVISERS 08/12/2025 39.10 K $262.71 K   8.26% 0.09%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2025 36.82 K $247.40 K   15.19% 0.09%
BANK OF AMERICA CORP /DE/ 08/14/2025 36.47 K $245.10 K   35.58% 0.09%
CORTON CAPITAL INC. 08/05/2025 28.76 K $193.23 K   100.00% 0.07%
PRUDENTIAL FINANCIAL INC 08/12/2025 28.34 K $190.45 K   23.38% 0.07%
UBS GROUP AG 08/14/2025 24.76 K $166.38 K   -51.49% 0.06%
DYNAMIC TECHNOLOGY LAB PRIVATE LTD 08/12/2025 24.73 K $166.00 K   100.00% 0.06%
INVESCO LTD. 08/13/2025 22.39 K $150.48 K   34.16% 0.05%
ROYAL BANK OF CANADA 08/14/2025 19.34 K $130.00 K   132.81% 0.05%
QUANTINNO CAPITAL MANAGEMENT LP 08/14/2025 18.62 K $125.14 K   100.00% 0.05%

Entrada Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 129 institutional investors and hedge funds held shares of Entrada Therapeutics, Inc.. The most heavily invested institutionals were:

BAKER BROS. ADVISORS LP: 4.87 M

MPM ASSET MANAGEMENT LLC: 4.38 M

5AM Venture Management, LLC: 4.31 M

PRICE T ROWE ASSOCIATES INC /MD/: 2.57 M

BlackRock, Inc.: 2.02 M

VANGUARD GROUP INC: 1.6 M

70.58% of Entrada Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 30.99 M shares in the last 24 months. This purchase volume represents approximately $190.91 M in transactions.